PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$36.32
-1.85% today
Updated 2026-06-05
Market cap
$1.25B
P/E ratio
13.21
P/S ratio
0.83x
EPS (TTM)
$2.33
Dividend yield
1.51%
52W range
$23 – $60
Volume
0.4M
Phibro Animal Health Corporation (PAHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$36.32
12-Month target
$71.25
2030 Target
—
Intrinsic (DCF)
$37.96
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.8B | $0.9B | $1.0B | $1.0B | $1.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 13.21x (capped 25x) · Margin: 6.35%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.